(Q67916106)
Statements
A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group (English)
S. Negoro
M. Fukuoka
H. Niitani
A. Suzuki
T. Nakabayashi
M. Kimura
M. Motomiya
Y. Kurita
K. Hasegawa